Recombinant Schizosaccharomyces pombe Diacylglycerol O-acyltransferase 1 (dga1)

How does S. pombe dga1 compare with orthologs from other species?

S. pombe dga1 is orthologous to diacylglycerol acyltransferases in various species, showing different degrees of sequence similarity:

The conservation pattern suggests functional significance across evolutionary lineages, particularly in organisms that synthesize and store triglycerides .

What expression systems yield optimal recombinant dga1 protein production?

The most effective expression system for producing functional recombinant S. pombe dga1 is E. coli. Commercial sources suggest specific approaches:

• Expression conditions:

  • Host: E. coli BL21(DE3) or similar strains

  • Vector: pET series with His-tag (preferably N-terminal due to membrane topology)

  • Induction: 0.5 mM IPTG at 18°C for 16-20 hours (lower temperatures improve solubility)

  • Media: 2× YT media supplemented with appropriate antibiotics

• Expression optimization:

  • Co-expression with chaperones (GroEL/GroES) can improve folding

  • Addition of 0.5% glucose to suppress basal expression before induction

  • Use of detergents (0.1% Triton X-100) during cell lysis helps solubilize the membrane-associated protein

Recombinant S. pombe dga1 is commercially available with His-tags, which facilitates purification while maintaining enzymatic activity .

What are effective methods for verifying dga1 activity after purification?

After purification, verification of dga1 activity is critical. Standard methods include:

• Enzymatic activity assay:

  • Substrate preparation: diacylglycerol and acyl-CoA

  • Reaction buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM DTT, 10 mM MgCl₂

  • Detection methods:

    • Radiometric assay using [¹⁴C]-labeled acyl-CoA

    • HPLC quantification of synthesized triacylglycerols

    • Fluorescent assay using NBD-labeled lipid substrates

• Western blot detection:

  • Using anti-dga1 antibodies (polyclonal antibodies from rabbit are commercially available)

  • Expected molecular weight: approximately 38-40 kDa

• Mass spectrometry verification:

  • Tryptic digest followed by LC-MS/MS to confirm protein identity

  • MALDI-TOF to verify intact protein mass

Maintaining the native conformation of dga1 is challenging due to its membrane association, requiring careful handling with appropriate detergents throughout the purification process .

How can recombinant dga1 be used to study triacylglycerol biosynthesis pathways?

Recombinant dga1 serves as a valuable tool for investigating triacylglycerol synthesis:

• In vitro reconstitution studies:

  • Combining purified dga1 with defined lipid substrates allows precise measurement of enzymatic parameters (Km, Vmax, substrate specificity)

  • Artificial liposomes containing dga1 can mimic cellular environments for studying membrane-dependent activity

• Inhibitor screening:

  • High-throughput assays using recombinant dga1 to identify compounds that modulate triacylglycerol synthesis

  • Structure-activity relationship studies of inhibitors provide insights into catalytic mechanism

• Protein interaction studies:

  • Pull-down assays using tagged dga1 to identify interaction partners

  • Proximity labeling in S. pombe cells expressing modified dga1 (similar to TurboID method described for other S. pombe proteins)

  • Co-immunoprecipitation followed by mass spectrometry to identify protein complexes involving dga1

These approaches provide mechanistic insights into triacylglycerol synthesis regulation in yeast and potentially other eukaryotes .

What genetic approaches can be used to study dga1 function in S. pombe?

S. pombe offers powerful genetic tools for investigating dga1 function:

• Knockout and complementation studies:

  • Generation of dga1Δ strains to assess phenotypic consequences

  • Complementation with wild-type or mutant dga1 variants to study structure-function relationships

  • Complementation with orthologs from other species to assess functional conservation

• Genomic integration strategies:

  • Site-specific integration techniques to introduce tagged versions of dga1

• Regulated expression systems:

  • nmt1 promoter series (strong, medium, weak) for thiamine-repressible expression

  • urg1 promoter system for faster induction (within 30 minutes) compared to nmt1 (14-20 hours)

• Meiotic recombination assays:

  • Methods for analyzing the effects of lipid metabolism genes on meiotic processes

  • Both random spore and tetrad analysis approaches are well-established for S. pombe

Researchers can leverage the extensive genetic toolbox available for S. pombe, with approximately 70% of its genes having human orthologs, making findings potentially translatable to human biology .

How does dga1 contribute to lipid droplet formation and dynamics in S. pombe?

Dga1 plays a crucial role in lipid droplet biogenesis through several mechanisms:

• Lipid droplet formation pathway:

  • Dga1 localizes to both the endoplasmic reticulum (ER) and lipid droplet (LD) surfaces

  • During LD biogenesis, dga1 generates triacylglycerols that accumulate between ER membrane leaflets

  • As lipid lenses grow, they eventually bud from the ER to form nascent LDs

  • Dga1 can subsequently relocate from the ER to the LD surface to continue TAG synthesis

• Quantitative contribution to TAG synthesis:

  • In S. pombe, dga1 is responsible for approximately 40-50% of total cellular triacylglycerol synthesis

  • The remainder is synthesized by other enzymes including phospholipid:diacylglycerol acyltransferase (PDAT)

• Regulation during nutrient stress:

  • During nitrogen starvation, dga1 expression and activity increase to promote TAG storage

  • Upon return to nutrient-rich conditions, LDs are mobilized for energy through lipase-mediated TAG hydrolysis

Advanced imaging techniques such as fluorescently tagged dga1 combined with LacO arrays at different genomic positions can be used to visualize dga1 dynamics in live cells .

What methods are available for studying post-translational modifications of dga1?

Post-translational modifications (PTMs) of dga1 represent an emerging area of research:

• Mass spectrometry-based PTM mapping:

  • Enrichment strategies for phosphorylated, acetylated, or ubiquitinated dga1

  • Targeted multiple reaction monitoring (MRM) assays for quantifying specific modifications

  • Crosslinking mass spectrometry to identify interaction surfaces modified by PTMs

• Genetic approaches for studying PTM-deficient variants:

  • Site-directed mutagenesis of predicted modification sites (Ser/Thr/Tyr for phosphorylation, Lys for acetylation/ubiquitination)

  • Integration of mutant variants into dga1Δ strains to assess functional consequences

• Tools for manipulating cellular kinase/phosphatase pathways:

  • Chemical inhibitors of specific signaling pathways

  • Temperature-sensitive alleles of signaling components (e.g., cdc2asM17 ATP-analogue sensitive allele)

  • Genetic deletion or overexpression of specific kinases/phosphatases

Researchers should consider leveraging S. pombe's advantages as a model organism, including its well-characterized cell cycle, to study regulation of dga1 activity in response to environmental changes and developmental signals .

What are common challenges in working with recombinant dga1 and how can they be addressed?

Several technical challenges are commonly encountered when working with dga1:

• Solubility and stability issues:

  • Challenge: As a membrane-associated protein, dga1 has limited solubility in aqueous buffers

  • Solution:

    • Use mild detergents (0.05-0.1% DDM, 0.5-1% CHAPS, or 0.01-0.05% LMNG)

    • Consider nanodiscs or amphipols for maintaining native conformation

    • Store with 20-50% glycerol at -80°C to prevent aggregation during freeze-thaw cycles

• Activity loss during purification:

  • Challenge: Significant reduction in enzymatic activity often occurs during purification

  • Solution:

    • Minimize purification steps and processing time

    • Include lipid additives (0.01-0.05 mg/ml total liver lipid extract)

    • Add reducing agents (1-5 mM DTT or 2-10 mM β-mercaptoethanol) to prevent oxidation of critical cysteine residues

• Expression toxicity in host cells:

  • Challenge: Overexpression can be toxic to E. coli hosts

  • Solution:

    • Use tightly controlled expression systems (T7lac promoter with glucose repression)

    • Reduce induction temperature to 16-18°C

    • Consider specialized E. coli strains designed for membrane protein expression (C41/C43)

• Substrate preparation difficulties:

  • Challenge: Diacylglycerol substrates have poor water solubility

  • Solution:

    • Prepare substrates in ethanol or DMSO (final concentration <2%)

    • Use mixed micelles with phospholipids or cyclodextrin carriers

    • Consider enzymatically generating substrates in situ using phospholipase C

These solutions have been optimized based on research experience with similar membrane-bound enzymes and can significantly improve experimental outcomes .

How can researchers design experiments to differentiate between dga1 and other acyltransferases?

Distinguishing dga1 activity from other acyltransferases requires careful experimental design:

• Substrate specificity profiling:

  • Compare activity with various acyl-CoA chain lengths (C8-C22) and saturation states

  • Test alternative acyl donors (acyl-CoA vs. acyl-carnitine vs. phospholipids)

  • Assess diacylglycerol substrates with different fatty acid compositions and stereochemistry

• Inhibitor panels for differentiation:

  • DGAT1 inhibitors (e.g., T863) vs. DGAT2 family inhibitors

  • Phospholipid synthesis inhibitors to rule out indirect effects

  • Species-specific inhibitor responses can help distinguish between paralogs

• Genetic approaches in S. pombe:

  • Create strains with specific acyltransferase deletions:

    • Single: dga1Δ

    • Double: dga1Δ + other acyltransferases

  • Measure residual TAG synthesis to determine relative contributions

  • Complementation with heterologous enzymes to assess functional conservation

• Subcellular localization studies:

  • Use fluorescent protein tagging to visualize distinct localization patterns

  • Apply subcellular fractionation followed by enzymatic assays

  • Perform protease protection assays to determine membrane topology

These approaches, combined with careful controls, allow researchers to attribute observed activities specifically to dga1 rather than related enzymes or non-enzymatic reactions .

How might structural studies of dga1 advance our understanding of acyltransferase mechanisms?

Structural characterization of dga1 represents a significant frontier in understanding triacylglycerol synthesis:

• Current structural knowledge gaps:

  • No high-resolution structure exists for any member of the DGAT2 family

  • Membrane integration topology remains partially characterized

  • Substrate binding sites and catalytic residues are predicted but not confirmed

• Promising structural biology approaches:

  • Cryo-electron microscopy with lipid nanodiscs

  • X-ray crystallography of soluble domains

  • Integrative modeling combining crosslinking mass spectrometry, EPR, and computational prediction

  • AlphaFold and other AI-based prediction methods for generating testable structural models

• Structure-guided enzyme engineering potential:

  • Rational design of dga1 variants with altered substrate specificity

  • Creation of chimeric enzymes with properties from multiple species

  • Development of biosensors by integrating dga1 domains with fluorescent reporters

Structural information would significantly accelerate understanding of both S. pombe and human diacylglycerol acyltransferases, potentially informing therapeutic development for metabolic disorders .

What are the implications of dga1 research for understanding human DGAT enzymes and metabolic disorders?

Research on S. pombe dga1 has several translational implications:

• Evolutionary conservation and divergence:

  • S. pombe dga1 shares significant sequence similarity with human MOGAT1/DGAT2 family

  • Conserved functional domains provide insight into essential catalytic mechanisms

  • Differences highlight species-specific adaptations in lipid metabolism

• Model system advantages for therapeutic development:

  • S. pombe genetic manipulation is simpler than mammalian systems

  • High-throughput screening capabilities for identifying DGAT modulators

  • Reconstituted enzyme systems for detailed biochemical characterization

• Potential biomedical applications:

  • Triglyceride synthesis inhibitors for metabolic disorders

  • Understanding rare genetic diseases involving acyltransferase deficiencies

  • Engineering yeast strains for production of specialized lipids for pharmaceutical applications

• Comparative biology insights:

  • Differing regulation of dga1 orthologs across species provides insight into metabolic adaptations

  • Conservation of protein-protein interactions suggests key regulatory mechanisms

  • Species-specific PTM patterns may explain metabolic differences

The high proportion (approximately 70%) of S. pombe genes with human orthologs makes findings particularly relevant to human biology, offering translational potential for metabolic research .